Concepedia

Publication | Open Access

Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients

DOIFull Paper Access

12

Citations

36

References

2023

Year

Chutima Seree-aphinan, Yanisa Ratanapokasatit, Poonkiat Suchonwanit, Ploysyne Rattanakaemakorn, Pichaya O-charoen, Prapaporn Pisitkun, Thanitta Suangtamai, Chavachol Setthaudom, Sonphet Chirasuthat, Kumutnart Chanprapaph
Frontiers in Immunology

Abstract

Nine months of rituximab-to-vaccination interval maximize the immunological benefits of COVID-19 vaccines while avoiding unnecessary delay in vaccination and rituximab treatment for IMDD patients.

References

YearCitations

Page 1